Can Wellbutrin and Vyvanse Be Taken Together?
Yes, Wellbutrin (bupropion) and Vyvanse (lisdexamfetamine) can be used together in adults without contraindications, though this combination requires careful monitoring for specific risks including serotonin syndrome, increased seizure risk, and cardiovascular effects.
Key Safety Considerations from FDA Labeling
The Vyvanse FDA label explicitly warns that "Taking VYVANSE with other medicines can cause serious side effects" and lists several medication classes requiring caution 1. While bupropion is not specifically contraindicated, the combination warrants attention due to overlapping mechanisms and potential adverse effects.
Primary Risks to Monitor
Serotonin Syndrome Risk
The FDA label warns about serotonin syndrome when Vyvanse is combined with medications affecting serotonergic pathways 1. While bupropion primarily affects norepinephrine and dopamine (not serotonin), watch for:
- Agitation, confusion, or hallucinations
- High body temperature and sweating
- Fast heartbeat
- Tremors or muscle stiffness
- Nausea, vomiting, or diarrhea
Seizure Risk Considerations
Bupropion carries inherent seizure risk that may be relevant in combination therapy. Research shows therapeutic doses of bupropion SR (up to 300 mg/day) have a seizure rate of 0.06-0.10% 2. However, bupropion accounts for approximately 1.4% of new-onset seizures presenting to emergency departments, making it the third leading cause of drug-related seizures after cocaine and benzodiazepine withdrawal 3.
Critical exclusion criteria:
- History of eating disorders (bulimia/anorexia) - seizure rates up to 7% in this population 4
- Sleep deprivation
- Heavy alcohol use history
- Personal or family history of seizures
Cardiovascular Monitoring
Both medications can increase heart rate and blood pressure. Monitor:
- Baseline and periodic blood pressure and heart rate
- Symptoms of palpitations or chest discomfort
Clinical Evidence for Combined Use
The 2002 AACAP practice parameter notes that bupropion has been used anecdotally as a second-line agent for ADHD 5. When ADHD and depression coexist, the guideline suggests performing a stimulant trial first due to rapid onset, then evaluating remaining depressive symptoms. If ADHD symptoms respond to stimulants but depression persists, adding an antidepressant is reasonable 5.
Recent evidence (2023) confirms bupropion's efficacy for depression is comparable to SSRIs, though its role in anxiety remains debated 6, 7. Bupropion's stimulating properties can provoke anxiety, particularly at higher doses 6.
Practical Implementation Algorithm
Start conservatively:
- Initiate bupropion at 150 mg SR once daily (or 100 mg IR twice daily)
- Stabilize Vyvanse dose before adding bupropion, or vice versa
- Avoid rapid dose escalations of either medication
- Maximum bupropion dose should not exceed 450 mg/day total
Monitor at 1-2 week intervals initially for:
- New or worsening anxiety, agitation, or insomnia
- Blood pressure and heart rate changes
- Any signs of serotonin syndrome
- Appetite suppression and weight loss (both medications cause this)
Important Caveats
Absolute contraindications to this combination:
- Current or past eating disorder diagnosis (bulimia nervosa or anorexia nervosa) - the combination of stimulants and bupropion in this population carries unacceptable seizure risk 4, 8
- Seizure disorder or predisposition
- Abrupt discontinuation of alcohol or sedatives
- Current use of MAO inhibitors
Relative cautions:
- Severe anxiety may worsen with this combination 6
- Both medications suppress appetite; monitor weight loss
- Sleep disturbances common with both agents
The combination is used in clinical practice, particularly when treating comorbid ADHD and depression, but requires vigilant monitoring and patient selection that excludes high-risk populations.